{"id":10372,"date":"2021-06-14T08:36:26","date_gmt":"2021-06-14T15:36:26","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=10372"},"modified":"2021-06-16T08:37:19","modified_gmt":"2021-06-16T15:37:19","slug":"impact-of-baseline-sars-cov-2-antibody-status-on-syndromic-surveillance-and-the-risk-of-subsequent-covid-19-a-prospective-multicentre-cohort-study","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/06\/14\/impact-of-baseline-sars-cov-2-antibody-status-on-syndromic-surveillance-and-the-risk-of-subsequent-covid-19-a-prospective-multicentre-cohort-study\/","title":{"rendered":"Impact of Baseline SARS-CoV-2 Antibody Status on Syndromic Surveillance and the Risk of Subsequent Covid-19 \u2013 a Prospective Multicentre Cohort Study"},"content":{"rendered":"<ul>\n<li style=\"font-weight: 400\"><i><span style=\"font-weight: 400\">[Pre-print, not peer-reviewed]<\/span><\/i><span style=\"font-weight: 400\"> The presence of <\/span><span style=\"font-weight: 400\">SARS-CoV-2 anti-nucleocapsid antibodies at baseline was associated with almost 80% protection against SARS-CoV-2 re-infection for a period of at least eight months, according to a study of healthcare workers (HCW) in Switzerland. Among 4,818 participants, 144 (3%) were seropositive at baseline. Among<\/span><span style=\"font-weight: 400\"> 2,713 participants with \u22651 SARS-CoV-2 test during follow-up, 3 of 67 (4.5%) seropositive individuals reported a positive result, compared to 547 of 2,646 (20.7%) seronegative participants (RR=0.22).<\/span><\/li>\n<\/ul>\n<p><i><span style=\"font-weight: 400\">Kohler et al.\u00a0(June 12, 2021). Impact of Baseline SARS-CoV-2 Antibody Status on Syndromic Surveillance and the Risk of Subsequent Covid-19 \u2013 a Prospective Multicentre Cohort Study. Pre-print downloaded Jun 14 from <\/span><\/i><a href=\"https:\/\/doi.org\/10.1101\/2021.06.09.21258422\"><span style=\"font-weight: 400\">https:\/\/doi.org\/10.1101\/2021.06.09.21258422<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[Pre-print, not peer-reviewed] The presence of SARS-CoV-2 anti-nucleocapsid antibodies at baseline was associated with almost 80% protection against SARS-CoV-2 re-infection for a period of at least eight months, according to a study of healthcare workers (HCW) in Switzerland. Among 4,818 participants, 144 (3%) were seropositive at baseline. Among 2,713 participants with \u22651 SARS-CoV-2 test during&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/06\/14\/impact-of-baseline-sars-cov-2-antibody-status-on-syndromic-surveillance-and-the-risk-of-subsequent-covid-19-a-prospective-multicentre-cohort-study\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[67,32],"topic":[31],"class_list":["post-10372","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-antibodies","tag-immunity","topic-vaccines-and-immunity"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/10372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=10372"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/10372\/revisions"}],"predecessor-version":[{"id":10373,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/10372\/revisions\/10373"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=10372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=10372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=10372"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=10372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}